Details of the Drug

General Information of Drug (ID: DMG8DDD)

Drug Name

VE800

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Live biotherapeutic product

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04208958) Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (Consortium-IO). U.S. National Institutes of Health.